By Julie Scharper
Roland Griffiths' psilocybin experiments have produced striking evidence for therapeutic uses of hallucinogens.
Read on hub.jhu.edu
CLEAR ALL
Study participants at some of the country's leading medical research centers are going through intense therapy and six-hour psychedelic journeys deep into their minds to do things like quit smoking and worry less.
2
Now, as a handful of patients and more recently doctors and therapists have been granted exemptions to use psilocybin, the nation’s federal health agency is considering making changes to existing policies that could open the door to much more than magic mushrooms.
1
Scientists Roland Griffiths and Matthew Johnson sit down with journalist Anderson Cooper to discuss the promise of psychedelics as a form of treatment for anxiety, depression, addiction, and more.
To understand the minds of individual cancers, we are learning to mix and match these two kinds of learning — the standard and the idiosyncratic — in unusual and creative ways.
A single dose of psilocybin, a compound found in “magic mushrooms,” provides long-term relief of anxiety and depression in cancer patients, a new study finds.
3
The new research looked at cancer patients who took part in a study nearly five years ago.
Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.
The author writes that what she does on behalf of healing any individual or being must also be healing, even if not directly extended, for the world itself.
In Melbourne's St Vincent's Hospital, down the hall from the cancer day unit, there's an unassuming room known simply as "The Retreat". This is where a select few volunteers are offered a unique opportunity: to confront their deepest fears under a heavy dose of a psychedelic.
Research into psychedelics, shut down for decades, is now yielding exciting results.